Date Time
Life-saving meningococcal B vaccination program continues indefinitely
South Australia’s world-leading Meningococcal B Immunisation Program will continue indefinitely after proving it’s been incredibly effective at preventing the illness in high-risk age groups.
It comes as a joint Women’s and Children’s Hospital and University of Adelaide study found the program has been key in a 60 percent reduction in cases among infants and a 73 percent drop in cases for adolescents.
“Our research found the immunisation program has been incredibly effective at preventing the illness in these age groups, which is largely due to the willingness of the community to get vaccinated and protect their babies, children and adolescents from the disease,”Professor in Vaccinology at the University of Adelaide, Professor Helen Marshall